IL10 and hepatocellular carcinoma: In contrast, IgA+ plasma cells expressing IL-10 or programmed death ligand 1 (PD-L1) dismantle the antitumor immunity of T cells in HCC and prostate cancer, whereas they are involved in the protective humoral response in ovarian cancer 58,60,68.